Melanoma Treatment Harnesses Immune System to Combat Cancer Cells
Wednesday, May 15, 2013 - 22:00
in Health & Medicine
Researchers reported that a combination of two drugs from Bristol-Myers Squibb appeared to shrink tumors in 41 percent of patients in a small study.